Cargando…
Redox Mechanisms in Cisplatin Resistance of Cancer Cells: The Twofold Role of Gamma-Glutamyltransferase 1 (GGT1)
Cisplatin (CDDP) is currently employed for the treatment of several solid tumors, but cellular heterogeneity and the onset of drug resistance dictate that suitable biomarkers of CDDP sensitivity are established. Studies on triple-negative breast cancer (TNBC) have recently confirmed the involvement...
Autores principales: | Pompella, Alfonso, Corti, Alessandro, Visvikis, Athanase |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163661/ https://www.ncbi.nlm.nih.gov/pubmed/35669424 http://dx.doi.org/10.3389/fonc.2022.920316 |
Ejemplares similares
-
Gamma-glutamyltransferases: exploring the complexity of a multi-functional family of enzymes
por: Franzini, Maria, et al.
Publicado: (2014) -
Serum Gamma Glutamyltransferase (GGT) in Coronary Artery Disease: Exploring the Asian Indian Connection
por: Singh, Kunal K., et al.
Publicado: (2022) -
Contribution by Polymorphonucleate Granulocytes to Elevated Gamma-Glutamyltransferase in Cystic Fibrosis Sputum
por: Corti, Alessandro, et al.
Publicado: (2012) -
Monocytes/macrophages activation contributes to b-gamma-glutamyltransferase accumulation inside atherosclerotic plaques
por: Belcastro, Eugenia, et al.
Publicado: (2015) -
Association between plasma gamma-glutamyltransferase fractions and metabolic syndrome among hypertensive patients
por: Franzini, Maria, et al.
Publicado: (2017)